You just read:

Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease

News provided by

Ionis Pharmaceuticals, Inc.

Dec 19, 2016, 16:02 ET